Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Source:
Evaluation of Coronavirus Disease 19 (COVID-19) Convalescent Plasma
Record details
-
Authors :
Hellenic Society of Hematology; Professor Meletios-Athanasios Dimopoulos, Professor & Rector of the NKU Athens Plasma Cell Dyscrasias Unit Section of Hematology & Medical Oncology Department of Clinical Therapeutics School of Medicine NKU Athens Alexandra Hospital
-
Source:
Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection - A Multicenter Phase II TrialPappa V, Bouchla A,
Record details
-
Source:
A Randomised Open-Label Trial of Early, Very High-Titre Convalescent Plasma Therapy in Clinically Vulnerable Individuals With Mild
Record details
-
Source:
A Multicenter Randomized Trial to Assess the Efficacy of CONvalescent Plasma Therapy in Patients With Invasive COVID-19 and Acute
Record details
-
Authors :
Joseph M. Flynn, D.O., MPH, Principal Investigator
-
Source:
Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) InfectionWu Z, McGoogan JM.
Record details
-
Source:
Multi-center, Randomized Clinical Trial of Convalescent Plasma Therapy Versus Standard of Care for the Treatment of COVID-19 in
Record details
-
Authors :
Gili Regev-Yochay MD, Infection Prevention & Control Unit, Director
-
Source:
Administering Convalescent Plasma Rich with Neutralizing Abs. to Hospitalized Adults with WNV - a Double-blind Randomized Controlled
Record details
-
Authors :
Andrew Eisenberger, Associate Professor of Medicine
-
Source:
A Phase 2 Randomized, Double-blinded Trial to Evaluate the Efficacy and Safety of Human Anti-SARS-CoV-2 Plasma for Early Treatment of COVID-19Arabi YM, Hajeer AH,
Record details
-
Source:
Therapeutic Plasma Exchange Followed by Convalescent Plasma Transfusion in Severe and Critically Ill
Record details
-
Source:
Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - CORIMUNO-CORIPLASM : EFFICACY OF
Record details
